|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.38 JOD | -7.38% |
|
-.--% | -3.50% |
Philadelphia Pharmaceuticals Company reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was JOD 8.4 million compared to JOD 8.42 million a year ago. Net income was JOD 0.807195 million compared to JOD 0.701114 million a year ago.
Basic earnings per share from continuing operations was JOD 0.108 compared to JOD 0.093 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.50% | 14.61M | |
| +19.27% | 43.75B | |
| +27.47% | 22.06B | |
| +15.11% | 14.46B | |
| +12.33% | 13.62B | |
| +38.36% | 11.61B | |
| -9.54% | 6.9B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +10.21% | 5.32B |
PHILADELPHIA PHARMACEUTICALS COMPANY 
